Aom0319 SAD Study in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 15, 2022

Primary Completion Date

December 13, 2023

Study Completion Date

December 21, 2023

Conditions

Healthy Volunteers

Interventions

DRUG

Adamgammadex Sodium

Aom0319 will be administered intravenously with water for injection.

DRUG

0.9% Sodium Chloride Injection

0.9% Sodium Chloride will be administered intravenously.

Trial Locations (1)

Nucleus Network Pty Ltd, Melbourne

All Listed Sponsors

lead

Amckaus PTY LTD.

INDUSTRY